Moderna, Inc. (NASDAQ: MRNA)

This investigation is for anyone who acquired securities in Moderna, Inc. (NASDAQ: MRNA) from August 19, 2026 through October 22, 2026.

The Law Offices of Howard G. Smith believes that the Company and certain of its executives violated federal law. Specifically, the Law Offices of Howard G. Smith believes that, throughout the time period mentioned above, the Company misled investors regarding its financial condition. More specifically, the Law Offices of Howard G. Smith believes that the Company misled investors by publishing a false report that combining the Moderna and Merck’s personalized mRNA cancer vaccine with Merck’s blockbuster immunotherapy Keytruda reduced the risk of melanoma returning or death by 42% compared with Keytruda alone.

On October 22, 2026, an early release of closely watched clinical trial results for the Moderna and Merck’s joint experimental cancer vaccine appeared on medical news website Oncology Central but were taken down shortly afterward. According to the briefly published report, combining the Moderna and Merck’s personalized mRNA cancer vaccine with Merck’s blockbuster immunotherapy Keytruda reduced the risk of melanoma returning or death by 42% compared with Keytruda alone. On this news, the price of the Company’s stock dropped precipitously on unusually heavy trading volume.

The Law Offices of Howard G. Smith seeks to recover damages on behalf of class members. If you acquired securities in Moderna, Inc. (NASDAQ: MRNA) from August 19, 2026 through October 22, 2026 you may join the lawsuit by submitting your information online, or you may call the Law Offices of Howard G. Smith and speak to Mr. Smith directly to learn how he can protect your rights.